NCT00094991View on ClinicalTrials.gov

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Muraglitazar

Trial Locations (2)

78229-3900

Local Institution, San Antonio

Unknown

Local Institution, Pisa

Sponsors
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY